1. Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom;
2. Leeds Institute of Medical Research, St. James’s University Hospital, University of Leeds, Leeds, United Kingdom;
3. Regenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Penang, Malaysia;
4. Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Freiburg, Germany;
5. Université de Paris, Institut Imagine, Paris, France;
6. Haematological Malignancy Diagnostic Service, St James’s University Hospital, Leeds, United Kingdom;
7. Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom;
8. Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom;
9. Department of Paediatrics, Leeds General Infirmary, Leeds, United Kingdom;
10. Department of Clinical Immunology and Allergy, St James’s University Hospital, Leeds, United Kingdom;
11. Department of Biosciences, Durham University, Durham, United Kingdom;
12. Wolfson Childhood Cancer Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, United Kingdom;
13. Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom;
14. Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; and
15. NIHR, Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine, Wellcome Trust Brenner Building, St James’s University Hospital, Leeds, United Kingdom